1. Home
  2. IMNM vs STNE Comparison

IMNM vs STNE Comparison

Compare IMNM & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$24.61

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo StoneCo Ltd.

STNE

StoneCo Ltd.

HOLD

Current Price

$15.09

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
STNE
Founded
2006
2012
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.3B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
IMNM
STNE
Price
$24.61
$15.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
8
Target Price
$32.80
$19.19
AVG Volume (30 Days)
1.2M
4.2M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
51.40
N/A
EPS
N/A
N/A
Revenue
$6,941,000.00
N/A
Revenue This Year
N/A
$14.84
Revenue Next Year
$1,127.34
$6.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.15
$11.95
52 Week High
$27.65
$19.95

Technical Indicators

Market Signals
Indicator
IMNM
STNE
Relative Strength Index (RSI) 66.42 56.55
Support Level $23.67 $14.36
Resistance Level $25.30 $15.93
Average True Range (ATR) 1.13 0.66
MACD 0.36 0.20
Stochastic Oscillator 94.87 69.21

Price Performance

Historical Comparison
IMNM
STNE

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

Share on Social Networks: